Invesco S&P Emerging Markets Low Volatility Index ETF (TSE:ELV – Get Free Report) was upgraded by investment analysts at Raymond James to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports.
Separately, Alliance Global Partners upgraded shares of Invesco S&P Emerging Markets Low Volatility Index ETF to a “strong-buy” rating in a report on Thursday, September 26th.
Read Our Latest Stock Analysis on Invesco S&P Emerging Markets Low Volatility Index ETF
Invesco S&P Emerging Markets Low Volatility Index ETF Price Performance
About Invesco S&P Emerging Markets Low Volatility Index ETF
Elevance Health Inc operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.
Featured Articles
- Five stocks we like better than Invesco S&P Emerging Markets Low Volatility Index ETF
- Trading Stocks: RSI and Why it’s Useful
- Procter & Gamble Proves It’s No Gamble: Uptrend Remains Strong
- The Significance of Brokerage Rankings in Stock Selection
- Should You Buy the Oil Dip? Top Energy Stocks to Hold Now
- What Does a Stock Split Mean?
- Market Momentum: 3 Stocks Poised for Significant Breakouts
Receive News & Ratings for Invesco S&P Emerging Markets Low Volatility Index ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco S&P Emerging Markets Low Volatility Index ETF and related companies with MarketBeat.com's FREE daily email newsletter.
